$INV insider fires shots at Innventure leadership, calls for mass layoffs and asset sales.
A former exec who claims to have built a $1B+ revenue business says Innventure's management has destroyed shareholder value through dilution (share count ballooned from ~50M to 80M+), self-dealing, and bloated overhead.
Key allegations:
• Former CEO Otworth ousted from PureCycle, later sued for fraud
• Management enriched insiders via related-party deals and stock grants
• Undisclosed capital funneled to Vital Energy drink
• Dark NX possibly fraudulent
The bright spot: Accelsius. The two-phase cooling play is positioned to dominate and could hit $4B market cap. Based on its last funding round, $INV should trade above $3/share but trades at a steep discount due to "hated" leadership.
New CEO Bill Grieco has "zero actual CEO experience" but may be well-intentioned. The author's prescription:
• Fire CFO Roland Austrup to clear out all tainted execs
• Slash overhead 95% to $3M/year
• Sell or shut down AeroFlex and Refinery
• Stop dilution and reclaim Vital Energy funds
If Innventure steps aside, Accelsius could raise at a $1B valuation and trigger a major stock rerate.
A former exec who claims to have built a $1B+ revenue business says Innventure's management has destroyed shareholder value through dilution (share count ballooned from ~50M to 80M+), self-dealing, and bloated overhead.
Key allegations:
• Former CEO Otworth ousted from PureCycle, later sued for fraud
• Management enriched insiders via related-party deals and stock grants
• Undisclosed capital funneled to Vital Energy drink
• Dark NX possibly fraudulent
The bright spot: Accelsius. The two-phase cooling play is positioned to dominate and could hit $4B market cap. Based on its last funding round, $INV should trade above $3/share but trades at a steep discount due to "hated" leadership.
New CEO Bill Grieco has "zero actual CEO experience" but may be well-intentioned. The author's prescription:
• Fire CFO Roland Austrup to clear out all tainted execs
• Slash overhead 95% to $3M/year
• Sell or shut down AeroFlex and Refinery
• Stop dilution and reclaim Vital Energy funds
If Innventure steps aside, Accelsius could raise at a $1B valuation and trigger a major stock rerate.